The administration of a single dose of a multivalent (DHPPiL4R) vaccine prevents clinical signs and mortality following virulent challenge with canine distemper virus, canine adenovirus or canine parvovirus

Article English OPEN
Stephen Wilson; Joanna Illambas; Elisabeth Siedek; Anne Thomas; Vickie King; Catrina Stirling; Edita Plevová; Jeremy Salt; Gordon Sture; (2014)
  • Publisher: Elsevier
  • Journal: Trials in Vaccinology,volume 3,pages102-106 (issn: 1879-4378)
  • Related identifiers: doi: 10.1016/j.trivac.2014.05.002
  • Subject: Vaccine | RM1-950 | Therapeutics. Pharmacology | Distemper | Adenovirus | Canine | Parvovirus
    mesheuropmc: viruses | cardiovascular system | animal diseases

Four challenge studies following vaccination of dogs with a multivalent vaccine containing canine parvovirus (CPV-2b), adenovirus (CAV-1/-2) and distemper (CDV) are described. Six week old puppies received a single vaccination while non-vaccinated control dogs received ... View more
Share - Bookmark